What is aducanumab? Aducanumab

What is aducanumab? and Who can take it?

What is aducanumab? Aducanumab is the Newest clinical treatment for Dementia and Alzheimer’s disease. Currently, The Drug-maker Biogen Agency Reviewed Aducanumab for Alzheimer’s In June 2022 and They Approved The Aducanumab (Aduhelm) as a New Treatment for Alzheimer’s Disease, But Since December 2021 A European Research Agency Refused this Drug to Use for Alzheimer’s Disease. …

What is aducanumab? and Who can take it? Read More »